| EXEL |
EXELIXIS, INC. |
15 Dec 2022 |
3 |
$-233,600 |
4 |
EVP, Scientific Strategy & CSO |
16 Dec 2022, 19:09 |
| EXEL |
EXELIXIS, INC. |
15 Nov 2022 |
1 |
$-119,928 |
4 |
EVP, Scientific Strategy & CSO |
17 Nov 2022, 19:42 |
| EXEL |
EXELIXIS, INC. |
03 Aug 2022 |
2 |
$-154,234 |
4 |
EVP, Scientific Strategy & CSO |
05 Aug 2022, 21:45 |
| EXEL |
EXELIXIS, INC. |
15 May 2022 |
1 |
$-122,950 |
4 |
EVP, Scientific Strategy & CSO |
17 May 2022, 20:22 |
| EXEL |
EXELIXIS, INC. |
04 Mar 2022 |
1 |
$0 |
4 |
EVP, Scientific Strategy & CSO |
08 Mar 2022, 19:52 |
| EXEL |
EXELIXIS, INC. |
15 Feb 2022 |
2 |
$-375,090 |
4 |
EVP, Scientific Strategy & CSO |
17 Feb 2022, 19:09 |
| EXEL |
EXELIXIS, INC. |
15 Dec 2021 |
5 |
$-612,407 |
4 |
EVP, Scientific Strategy & CSO |
17 Dec 2021, 19:35 |
| EXEL |
EXELIXIS, INC. |
15 Nov 2021 |
6 |
$-1,689,450 |
4 |
EVP, Scientific Strategy & CSO |
17 Nov 2021, 19:02 |
| EXEL |
EXELIXIS, INC. |
15 Oct 2021 |
3 |
$-746,225 |
4 |
EVP, Scientific Strategy & CSO |
15 Oct 2021, 20:15 |
| EXEL |
EXELIXIS, INC. |
30 Sep 2021 |
2 |
$-148,062 |
4 |
EVP, Scientific Strategy & CSO |
04 Oct 2021, 20:02 |
| EXEL |
EXELIXIS, INC. |
15 Sep 2021 |
3 |
$-676,875 |
4 |
EVP, Scientific Strategy & CSO |
17 Sep 2021, 19:56 |
| EXEL |
EXELIXIS, INC. |
16 Aug 2021 |
3 |
$-909,700 |
4 |
EVP, Scientific Strategy & CSO |
18 Aug 2021, 19:56 |
| EXEL |
EXELIXIS, INC. |
15 Jul 2021 |
3 |
$-934,200 |
4 |
EVP, Scientific Strategy & CSO |
16 Jul 2021, 19:58 |
| EXEL |
EXELIXIS, INC. |
17 Jun 2021 |
3 |
$-1,216,800 |
4 |
EVP, Scientific Strategy & CSO |
22 Jun 2021, 20:03 |